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During the last few years, genotoxicity bio-
markers have received considerable interest
as tools for detecting human genotoxic
exposure and effects, especially in health
surveillance programs dealing with occupa-
tional exposure to chemical carcinogens.
Currently, only cytogenetic end points in
peripheral blood lymphocytes allow a rea-
sonable epidemiologic evaluation of cancer
predictivity. The largest databases are avail-
able for chromosomal aberrations (CA);
high CA level has been associated with
increased cancer risk (1,2). Evaluations have
also been performed for lymphocyte sister
chromatid exchanges (SCEs) and micronu-
clei (MN), but thus far these biomarkers
have not been shown to predict cancer
(1,2). These findings may reflect the rela-
tively small databases, the comparatively
young cohorts, and variation in techniques,
which have made it difficult to standardize
individual SCE and MN values obtained
from different sources. In a few years, accu-
mulation of more uniform data will make it
possible to reassess the value of both SCEs
and MN. In the meantime, SCEs and MN
are used as biomarkers of genotoxic expo-
sure, as simpler alternatives to CA analysis.
In the present study, we applied these meth-
ods to monitor solvent-exposed workers
from two Bulgarian shoe factories.
People employed in the shoemaking
industry are at an increased risk of leukemia
and nasal cancer (3), and an excess of mor-
tality due to other types of cancer has also
been reported (4–6). Workers in shoe and
boot factories are exposed to a mixture of
organic solvents, among which toluene and
acetone are usually the most common.
Neither of these solvents is considered a
genotoxin or a carcinogen; the weight of evi-
dence from human in vivo studies suggests
that exposure to toluene does not cause
somatic cell genotoxic damage (7), although
this view has been questioned by recent
studies of rotogravure printers (8,9).
The glues and gasoline used in shoe
manufacture may contain benzene, which
could be responsible for some of the cancers
found in shoe workers. Benzene is a well-
known clastogen that requires metabolic
activation to be mutagenic. The genotoxic
metabolites are also thought to play an
important role in benzene myelotoxicity and
leukemogenesis. The quinone metabolites of
benzene can break chromosomes by induc-
ing reactive oxygen species but may also act
as aneuploidogens, causing microtubule dis-
ruption (10,11). Recent investigations have
indicated that structural CA are increased in
shoe factory workers exposed to benzene and
toluene (12,13).
In a preliminary study of the genotoxic
effects of occupational exposure to organic
solvents, using the alkaline Comet assay, we
did not detect any increase in DNA damage
in cryopreserved peripheral blood mono-
nuclear leukocytes from a group of women
employed in the two Bulgarian shoe factories
(14). 
Here we report results of lymphocyte
SCE and MN analyses in a larger group of
shoe workers from the same plants. We also
present MN data from three other cross-sec-
tional studies conducted 2–5 years earlier
than the last sampling. In all cases, the con-
centrations of toluene, gasoline, acetone,
ethylacetate, and methylenediphenyl diiso-
cyanate (MDI) in workplace air and the con-
centration of hippuric acid (HA) in the
urine were determined. To evaluate whether
genetically determined individual variations
in xenobiotic metabolizing capacity modified
individual susceptibility to the possible geno-
toxic effects of the occupational exposure, we
examined the subjects for their glutathione
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Articles
We examined sister chromatid exchanges (SCEs) and micronuclei (MN; cytokinesis-block
method) in cultured peripheral lymphocytes from 52 female workers of two shoe factories and
from 36 unexposed age- and sex-matched referents. The factory workers showed an elevated level
of urinary hippuric acid, a biomarker of toluene exposure, and workplace air contained high con-
centrations of various organic solvents such as toluene, gasoline, acetone, and (in one of the plants
only) ethylacetate and methylenediphenyl diisocyanate. The shoe factory workers showed a statis-
tically significant higher frequency of micronucleated binucleate lymphocytes in comparison with
the referents. This finding agreed with three preliminary MN determinations (each comprising
27–32 shoe workers and 16–20 controls) performed in one of the plants 2–5 years earlier. The
shoe factory workers also had a lower average level of blood hemoglobin than the referents. In
contrast, no difference was found between the groups in SCE analysis. Smokers showed signifi-
cantly higher mean frequencies of SCEs per cell and high frequency cells (HFC) than nonsmok-
ers. Aging was associated with increased MN rates and reduced cell proliferation. Polymorphism
of the glutathione S-transferase M1 gene (GSTM1) did not affect the individual level of SCEs;
but in smoking shoe workers an effect of the occupational exposure on the frequency of micronu-
cleated cells could be seen only in GSTM1 null subjects. The low prevalence of the glutathione S-
transferase T1 (GSTT1) null genotype precluded the evaluation of the influence of GSTT1
polymorphism. Our results show that the shoe factory workers have experienced genotoxic expo-
sure, which is manifest as an increase in the frequency of MN, but not of SCEs, in peripheral
lymphocytes. The exposures responsible for the MN induction could not be identified with cer-
tainty, but exposure to benzene in gasoline and methylenediphenyl diisocyanate may explain
some of the findings. Key words: glutathione S-transferase M1, glutathione S-transferase T1,
micronuclei assays, shoe factory workers, sister chromatid exchange assays, solvent exposure.
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S-transferase M1 (GSTM1) and T1 (GSTT1)
genotypes.
Materials and Methods
Subjects studied. We conducted four inde-
pendent biomonitoring studies of Bulgarian
shoe factory workers in 1992, 1993, 1995,
and 1997. In the first three years, only work-
ers from plant B (Gabrovo) were examined;
the last survey also included subjects from
plant A (Sofia). In 1997, we examined 33
workers from plant A and 19 from plant B.
The control group consisted of 36 unex-
posed women from the administrative staff
of these plants. The subjects represented
about half of the staff in each factory and
were chosen randomly. In general, the work-
ers participated in the study only once,
except for a few individuals who were
included in two or three of the samplings.
All subjects gave written informed consent
and were interviewed for personal data,
duration of employment, and smoking
habits. The characteristics of the studied
groups are summarized in Table 1. The sub-
jects were all women, except eight control
subjects and three exposed workers enrolled
in 1992. In all cases, the numbers of smokers
among the controls and the exposed subjects
were adequately matched, except in the
1993 study, where the number of smokers
was higher among the controls than among
the exposed. In the shoe factory workers, the
total duration of occupational exposure
gradually increased during the follow-up
period; the difference in the average time of
employment in the plant between the first
and the last sampling was 3 years. 
Exposure measurements. We used special
diffusive monitors (Hygitest Co., Sofia,
Bulgaria) placed at breath level to obtain
workplace vapor samples. The average
concentrations of gasoline and methyl-
enediphenyl diisocyanate (MDI) were mea-
sured by express linear-colorimetric method.
We measured environmental levels of
toluene, acetone, and ethylacetate with an
infrared gas chromatography analyzer Miran
1B2 (Foxboro, MA, USA). We monitored
these substances in workplace air according
to the Bulgarian analytic protocols (15) and
Bulgarian Health Ministry’s Order (16).
Because the administrative staff was expected
to be exposed to very low environmental lev-
els of organic solvents, compared with the
exposed workers, and given the results of
earlier studies (17–19), exposure values for
control subjects included in this study were
taken to be zero. The mean workplace levels
(milligrams per cubic meter) of some organic
solvents in the shoe factories are shown in
Table 2, expressed as time-weighted average
(8-hr TWA) values. It is evident that the
shoe workers were exposed to a complex
mixture of solvents. In most cases, the con-
centrations of these solvents clearly exceeded
the limits recommended by European and
American standards (20–22).
As a biomarker of toluene exposure,
urine samples were collected in the end of
the working day, also from the controls, and
were analyzed for HA, according to a
method previously described (23). As can be
seen from Table 3, the shoe factory workers
showed a marked increase in the mean HA
levels, with a statistically significant differ-
ence from controls [p < 0.001; analysis of
variance (ANOVA)] in each sampling. A sig-
nificant relationship between HA concentra-
tions in urine and toluene air levels was
found in the entire population studied (β =
0.651, p < 0.001). The presence of phenol,
the main urinary metabolite of benzene, was
analyzed (24) in urine samples from 29 shoe
factory workers and 16 controls included in
the 1992 study. As there were no differences
between these groups in urinary phenol lev-
els (exposed: 0.12 ± 0.03 mmol/L; controls:
0.10 ± 0.02 mmol/L; detailed data not
shown), the workers did not appear to be
exposed to high levels of benzene. However,
urinary phenol may not reliably indicate
lower benzene exposures from gasoline, but
these benzene levels may have genotoxic
effects.
We analyzed the glues used in these
plants in 1997 for benzene content, using a
gas chromatograph with a mass-spectromet-
ric detector (Hewlett-Packard 6890/5972A,
Wilmington, DE, USA). We detected no
benzene traces in these glues.
Blood collection. Heparinized venous
blood samples were drawn from each donor,
and hemoglobin values were measured in
Bulgaria by standard methods. In the 1992,
1993, and 1995 studies, the blood samples
were processed in Bulgaria, and blood cul-
tures were set up in a few hours after sam-
pling. To carry out the 1997 study, the
blood samples were sent to Barcelona and
were put in culture within 48 hr after the
collection. Briefly, the blood samples were
centrifuged at 170 g for 5 min, the plasma
was removed, and RPMI 1640 culture
medium (GIBCO, Eragny, France) was
added to each blood pellet to attain its initial
volume. 
Sister chromatid exchanges. We per-
formed the SCE assay only for blood sam-
ples obtained in 1997, following standard
methodology (25). Briefly, two whole-blood
lymphocyte cultures were set up for each
donor, and the cultures were incubated cov-
ered from light for 72 hr in the presence of
5-bromodeoxyuridine (BrdU; final concen-
tration 8 µg/mL). The cultures were treated
with colcemid for the last 2 hr, and the cells
were then harvested, treated with hypotonic
solution (0.075 M KCl) for 20 min, and
fixed three times with methanol-glacial
acetic acid. Microscopic slides were prepared
from the fixed cells by air drying, and the
slides were stained by the fluorescence-plus-
Giemsa procedure (26). We purchased BrdU
and Hoechst 33258 from Eastman Kodak
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Table 1. Characteristics of the exposed shoe workers and control subjects studied.
Age, years Duration of employment, No. of smokers
Year, group No. (mean ± SD) years (mean ± SD) (%)
1992
Controls 16 35.3 ± 7.9 — 8 (50.0)
Exposed 32 38.8 ± 9.4 9.7 ± 9.5 15 (46.9)
1993
Controls 19 40.2 ± 7.8 — 12 (63.2)
Exposed 27 38.2 ± 8.0 11.1 ± 10.1 9 (33.3)
1995
Controls 20 38.4 ± 10.3 — 10 (50.0)
Exposed 27 38.4 ± 8.3 12.3 ± 9.7 16 (59.3)
1997
Controls 36 43.7 ± 8.2 — 16 (44.4)
Exposed 52 40.7 ± 8.8 12.8 ± 10.5 29 (55.8)
Table 2. Concentrations (milligrams per cubic meter) of some solvents in workplace air of two shoe factories.a
Year Plant Toluene Gasoline Acetone Ethylacetate Diisocyanate
1992 B 275 ± 123 (100–410) 746 ± 430 (422–1,477) 628 ± 363 (159–1,003) —b —b
1993 B 235 ± 64 (68–618) 1,334 ± 247 (450–2,800) 539 ± 252 (24–1,744) —b —b
1995 B 148 ± 104 (18–320) 300 ± 126 (150–600) 960 ± 955 (55–2,900) 93 ± 82 (7–360) 0.21 ± 0.07 (0.06–0.29)
1997 A 76 ± 11 (66–96) 457 ± 45 (392–526) 374 ± 17 (341–389) —b —b
B 236 ± 125 (137–412) 468 ± 201 (283–723) 764 ± 189 (523–927) 246 ± 105 (164–400) 0.23 ± 0.08 (0.15–0.34)
aMeasured during an 8-hr workshift, except for diisocyanate, which was measured during a 15-min exposure. Values shown are mean ± SD (range). bNot used. 
(Rochester, NY, USA), and Giemsa from
Merck (Darmstadt, Germany). 
For each donor, we analyzed 50
metaphases (25/replicate) on coded slides
to determine the frequency of SCEs per
cell. The analysis was conducted by two
scorers, one per replicate. We estimated the
percentage of high frequency cells (HFC) for
each individual using the pooled distribution
of all SCE measurements. We defined HFC
as cells with SCE number over the 95th per-
centile of the distribution of SCEs per cell in
the whole population. We examined 100
metaphases to calculate the proliferation rate
index (PRI) (27). 
Micronuclei. Whole blood cultures for
the cytokinesis-block MN test were estab-
lished according to Surrallés et al. (28),
with some minor adaptations to the specific
conditions of the Sofia and Barcelona labo-
ratories. In both cases, the cultures were
incubated at 37ºC for 72 hr and, at 44 hr
after initiation of the cultures, cytochalasin-
B (Sigma Chemicals, St. Louis, MO, USA)
was added at a concentration of 6 µg/mL.
The cells were harvested, treated with a
mild hypotonic solution (0.075 M KCl) for
2–3 min, and gently fixed three times using
methanol/acetic acid (5:1) solution. Air-
dried preparations were made, and the
slides were stained in a 10% (v/v) solution
of Giemsa in phosphate buffer (pH 6.8) for
20 min.
We examined 1,000 binucleate cells for
each subject on coded slides (the same scorer
in Barcelona and Bulgaria), and the total
numbers of MN and the frequency of binu-
cleate cells with MN (BNMN) were scored.
We scored 500 lymphocytes to evaluate the
percentage of cells with 1, 2, 3, or 4 nuclei,
and we calculated the cytokinesis-block pro-
liferation index (CBPI) according to
Surrallés et al. (29).
Genotype analysis. We used genomic
DNA extracted from leukocytes by stan-
dard methods as a template in the GSTM1
and GSTT1 genotype analyses, as described
elsewhere (30). Briefly, the GSTM1 and
GSTT1 genotypes were determined simulta-
neously in a multiplex polymerase chain
reaction (PCR) approach using β-globin spe-
cific primers in addition to the GSTM1 and
GSTT1 specific primer pairs. The presence
of the β-globin specific signal verified the
proper functioning of the PCR reaction,
whereas the absence of GSTM1 and GSTT1
specific amplification products revealed the
corresponding null genotypes.
Statistical analysis. For the cross-
sectional studies performed in 1992–1997,
all variables analyzed were compared with
the normal distribution by the Kolmogorov-
Smirnov test of goodness of fit. The distrib-
utions of our data did not significantly
depart from normality (p > 0.05) in any
case, so parametric tests were adequate for
the statistical analysis.
For each independent study, the effects
of various factors on HA, hemoglobin,
BNMN, and SCEs were simultaneously
assessed by the ANOVA. These factors were
occupational exposure, smoking, and, if
available, GST genotypes, and we considered
the age of the subjects as a covariate. To
determine the relationship between solvent
exposure levels and both HA and hemoglo-
bin data, we applied a multiple regression
analysis in the whole population. To this
effect, from those subjects sampled several
times, only the latest results were included in
the analysis. Because of the low prevalence of
the GSTT1 null genotype, GSTT1 genotype
was not included as an independent variable
in the analysis. The results were analyzed
using the CSS: STATISTICA/W (StatSoft,
Tulsa, OK, USA) statistical package.
Results
As shown in Table 3, the hemoglobin values
of shoe factory workers were reduced
compared those of nonexposed women. This
difference, apparently stemming from the
occupational exposure, reached statistical
significance (p < 0.001) in the ANOVA. 
In 1992–1995, we used the MN assay to
assess whether the occupational exposure of
the shoe factory workers could exert some
genotoxic effects. We observed significant
increases in the mean frequency of BNMN
of the exposed groups each year in compari-
son with the respective control groups
(Figure 1). Especially noteworthy was the
constant increase in the mean frequency of
BNMN in the exposed groups from 1992
(38.00, SD 20.18) to 1995 (55.2, SD 17.1),
whereas control subjects consistently showed
similar basal mean values (from 18.6, SD 6.3
to 22.0, SD 10.0).
In the last study, carried out in 1997
and involving both factories, the MN assay
confirmed our previous positive findings.
Table 4 shows the MN and SCE results,
separately for nonsmokers and smokers,
among the controls and exposed workers. In
the multiple ANOVA, occupational expo-
sure (plant A, plant B, and controls) consti-
tuted a statistically significant (p < 0.001)
source of variation for the BNMN values.
The post hoc least squares difference test
showed that workers of plant B had a clearly
higher BNMN frequency (p < 0.001) than
controls or plant A workers, but also plant A
workers differed significantly (p = 0.035)
from the controls. We detected no effect on
cell-cycle kinetics, measured as CBPI, as a
consequence of the solvent exposure.
In the SCE assay (Table 4), we were not
able to detect any genotoxic effect related to
occupational exposure. We found no corre-
lation between MN and SCEs. The occupa-
tional exposure was associated with a slight
decrease in PRI (p = 0.048). 
Age was a significant covariate (p =
0.006) in the multiple analysis of variance
of the 1997 BNMN data, reflecting an
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Table 3. Urinary hippuric acid and blood hemoglobin levels in exposed shoe workers and control subjects
(means ± SD). 
Year, group (plant) No. Hippuric acid Hemoglobin 
1992
Controls 16 0.53 ± 0.28 150.50 ± 9.97
Exposed (plant B) 32 3.05 ± 2.14 123.00 ± 9.56
1993
Controls 14 0.91 ± 0.64 131.83 ± 13.59
Exposed (plant B) 26 2.97 ± 1.51 124.38 ± 11.72
1995
Controls 20 0.34 ± 0.16 141.80 ± 8.76
Exposed (plant B) 27 1.56 ± 1.55 115.04 ± 8.99
1997
Controls 36 0.48 ± 0.31 139.42 ± 12.44
Exposed (total plants A and B) 52 2.26 ± 1.63 124.06 ± 13.52
Exposed (plant A) 33 1.90 ± 1.05 128.64 ± 14.02
Exposed (plant B) 19 2.87 ± 2.22 116.11 ± 7.94
Figure 1. Mean (+ SD) frequencies of binucleate
lymphocytes with BNMN in shoe factory workers
of plant B and in unexposed controls (first three
samplings). In the multiple analysis of variance,
occupational exposure was a statistically signifi-
cant (p < 0.001) source of variation for each sam-
pling. In the 1995 collection, age (p = 0.024) and
smoking (p = 0.021) were also significant vari-
ables. The numbers of subjects studied in 1992,
1993, and 1995 were, respectively, 32, 27, and 27
for the shoe factory workers and 16, 19, and 20 for
the controls.
80
70
60
50
40
30
20
10
0
B
N
M
N
1992 1993 1995
Control
Exposed
age-dependent increase in BNMN fre-
quency. Age appeared to be partially associ-
ated with a decreased cell proliferation, as
indicated by its significant effect on PRI (p =
0.001); CBPI was not affected by age. In the
same analysis, smoking did not significantly
affect BNMN frequencies in the 1997 study.
However, both the mean frequency of SCEs
per cell (p = 0.006) and the mean number of
HFC (p = 0.004) were increased by smok-
ing. This smoking-related effect was stronger
among the controls than among plant A
workers (p < 0.05 in both cases; t-test), but it
did not attain statistical significance among
plant B workers.
In agreement with reported frequencies
for Caucasian populations, the prevalence of
GSTM1 and GSTT1 null subjects in the
1997 study was 56.8% and 13.6%, respec-
tively (Table 5). When the few GSTT1 null
subjects were removed for a subsequent
ANOVA (including occupational exposure,
smoking, and GSTM1 genotype as indepen-
dent factors and age as a covariate), neither
the MN nor the SCE assay outcome was sig-
nificantly affected by the GSTM1 genotype.
However, considering plant A and B workers
together, the post hoc least squares difference
test indicated a higher BNMN frequency in
the exposed than the controls in GSTM1
null subjects among both smokers (p =
0.006) and nonsmokers (p = 0.003), but in
GSTM1 positive subjects only among non-
smokers (p = 0.017). Tables 6 and 7 show
the average of BNMN, CBPI, SCEs, HFC,
and PRI values for GSTM1 positive and
GSTM1 null subjects among the different
subgroups.
Discussion
The present study showed an increased fre-
quency of MN in peripheral lymphocytes of
shoe factory workers exposed to a mixture of
organic solvents. In plant B, where lympho-
cyte MN frequencies were followed up over
5 years, all four samplings yielded the same
result. Although the shoe factory workers did
not show any effects in the frequency of
SCEs, HFC, or DNA breakage, as measured
earlier by the Comet assay (14), our findings
indicate the presence of genotoxic exposure
at the workplace. This would appear to act
via an aneugenic or clastogenic mechanism
that does not involve DNA breakage readily
detectable by the Comet assay and that does
not efficiently lead to SCE formation.
In interpreting these findings, one must
consider that although there are several exam-
ples of MN induction in human binucleated
lymphocytes by known clastogenic exposures
in vivo, evidence that the in vivo effects of an
aneugen can be expressed in the first in vitro
division of a binucleated cell is scanty (31,32).
The binucleated cells that are exclusively ana-
lyzed in the cytokinesis-block MN assay have,
by definition, completed their first in vitro
mitosis, and most MN observed in such cells
have been formed in the culture. Thus, an in
vivo MN inducer would have to be able to
initiate its effect in the resting G0 lymphocyte.
Further studies of the shoe factory workers
using CA analysis or an MN assay incorporat-
ing pancentromeric fluorescence in situ
hybridization or antikinetochore antibodies to
identify the contents of the MN will be useful
in identifying the nature of the exposure that
produced the excess MN.
Although the glues used in the factories
did not contain measurable amounts of ben-
zene, there probably was benzene in the
gasoline used as solvent. The air concentra-
tions of gasoline were high, and benzene
may well be the principal agent responsible
for the observed genotoxic effects. In factory
B, the levels of MDI (measured as diiso-
cyanate) were very high and could explain
some of the genotoxic effects. MDI is highly
reactive and induced CA in human lympho-
cytes in vitro (33). MN frequencies were
clearly higher in plant B than in plant A, and
this could be caused by MDI, since diiso-
cyanate was not found at all in plant A. Even
in plant B, diisocyanate was not discovered
during the first three sample collections.
Thus, although it may not be possible to
point out a single genotoxic agent at the
workplace, benzene in gasoline and MDI
may explain some of the findings. A possible
indication of the heavy organic solvent expo-
sure of the workers was the consistently low-
ered blood hemoglobin level, which we also
observed in the previous study (14). Anemia
and other hematologic abnormalities have
been associated with organic solvent expo-
sure in Bulgarian petroleum workers (34).
Several investigations have suggested an
increased sensitivity of the GSTM1 null
genotype to genotoxicity induced by various
exposures, including tobacco smoke
(35–47). Such an association was not, how-
ever, unequivocally demonstrated in most of
the few studies where SCEs or MN were
used as biomarkers (48–58). Nevertheless,
our MN results appear to support the
increased sensitivity of the GSTM1 null
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Table 4. Mean (± SD) frequencies of BNMN and SCEs in lymphocytes of shoe factory workers of plants A and B and unexposed controls, according to smoking
habit (last sampling).
Micronucleus assaya SCE assayb
Group No. No. BNMN/1,000 cells CBPI No. No. SCEs/cell Percent HFC PRI
Controls
Nonsmokers 20 24.15 ± 7.49 1.89 ± 0.16 15 7.83 ± 1.04 2.67 ± 2.47 2.26 ± 0.24
Smokers 16 22.19 ± 8.45 1.87 ± 0.11 13 9.05 ± 1.73 8.37 ± 9.26 2.32 ± 0.12
Plant A workers
Nonsmokers 15 31.13 ± 10.01 1.93 ± 0.08 15 7.59 ± 0.86 2.53 ± 2.45 2.15 ± 0.16
Smokers 18 25.28 ± 12.13 1.89 ± 0.09 18 8.47 ± 1.10 6.11 ± 5.29 2.28 ± 0.28
Plant B workers
Nonsmokers 8 47.25 ± 9.10 1.85 ± 0.20 8 7.77 ± 0.80 4.25 ± 3.62 2.29 ± 0.10
Smokers 11 43.45 ± 13.47 1.95 ± 0.17 11 8.15 ± 1.34 5.17 ± 4.98 2.38 ± 0.10
Total
Controls 36 23.28 ± 7.87 1.88 ± 0.14 28 8.40 ± 1.51 5.31 ± 7.05 2.29 ± 0.19
Plant A workers 33 27.94 ± 11.44 1.91 ± 0.09 33 8.07 ± 1.08 4.48 ± 4.55 2.22 ± 0.24
Plant B workers 19 45.05 ± 11.69 1.91 ± 0.19 19 7.99 ± 1.13 4.76 ± 4.37 2.34 ± 0.11
aBNMN/1,000 cells was affected by occupational exposure (p < 0.001) and age (a covariate; p = 0.006) in analysis of variance. bSmoking affected no. SCEs/cell (p = 0.006) and HFC (p =
0.004) in analysis of variance.
Table 5. Distribution of GSTM1 and GSTT1 genotypes among exposed shoe factory workers and control subjects in 1997.
Controls Exposed Total
Genotypes No. Percent No. Percent No. Percent
GSTM1 + GSTT1 + 13 36.1 19 36.5 32 36.4
GSTM1 + GSTT1 null 4 11.1 2 3.8 6 6.8
GSTM1 null GSTT1 + 16 44.5 28 53.9 44 50.0
GSTM1 null GSTT1 null 3 8.3 3 5.8 6 6.8
genotype, because in smokers an occupa-
tional exposure effect could be seen only
among GSTM1 null subjects. Although this
finding is based on a few individuals, it
could indicate, for example, that smoking
induces GSTM1 activity in GSTM1-profi-
cient individuals, which would protect them
from the genotoxic effects of the occupa-
tional exposure. Smoking is not known to
markedly induce GSTM1 in humans in
vivo. At present, the possible effect of
GSTM1 genotype on MN formation is not
well understood. Our previous studies sug-
gested that the baseline level of MN is
decreased in GSTM1 null subjects (55).
In one investigation, the GSTM1 null
genotype was described to increase SCEs in
smokers, although the difference to GSTM1
positive smokers was quite small (0.23
SCEs/cell) and was statistically significant
only in heavy smokers (0.53 SCEs/cell) (48).
An increase of this magnitude may have
been undetected in the present study. An
effect of GSTM1 polymorphism on the base-
line level of SCEs in nonsmokers was
reported by Cheng et al. (59,60), but this
finding has not been reported in other stud-
ies (52–54,57), and it was not supported by
our data.
In contrast, there is some evidence that
the GSTT1 null genotype is associated with
an increased baseline frequency of SCEs
(61–64) and possibly also CA (54,65). This
finding does not appear to be explained by
smoking or other known exposures.
Unfortunately, we could not properly evalu-
ate the effects of GSTT1 polymorphisms
because of the low frequency of the GSTT1
null genotype.
In conclusion, our results indicate that
the shoe factory workers studied have experi-
enced genotoxic exposure, which is mani-
fested as an increase in the frequency of
MN, but not of SCEs, in peripheral lym-
phocytes. The workers also showed a reduc-
tion in blood hemoglobin values. Although
high air concentrations of several organic
solvents were found at the factories, the
exposures responsible for the MN induction
could not be identified with certainty.
Exposure to benzene in gasoline and MDI
may explain some of the findings.
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Table 6. Mean (± SD) frequency of BNMN and CBPI in shoe factory workers and unexposed controls,
according to smoking and GSTM1 genotype (last sampling).
Group, smoking habit Genotype No. No. BNMN/1,000 cellsa CBPI
Controls
Nonsmokers GSTM1 null 7 22.43 ± 7.44 1.89 ± 0.21
GSTM1 + 8 22.38 ± 4.81 1.89 ± 0.14
Smokers GSTM1 null 9 19.89 ± 8.34 1.84 ± 0.15
GSTM1 + 5 25.20 ± 10.03 1.89 ± 0.03
Plant A workers
Nonsmokers GSTM1 null 7 30.29 ± 11.24 1.91 ± 0.07
GSTM1 + 7 31.29 ± 10.14 1.94 ± 0.08
Smokers GSTM1 null 11 27.82 ± 14.35 1.90 ± 0.07
GSTM1 + 6 21.17 ± 7.19 1.91 ± 0.12
Plant B workers
Nonsmokers GSTM1 null 4 47.50 ± 11.68 1.92 ± 0.13
GSTM1 + 3 48.33 ± 8.62 1.73 ± 0.29
Smokers GSTM1 null 6 45.00 ± 13.83 2.00 ± 0.19
GSTM1 + 3 33.33 ± 12.50 1.94 ± 0.20
aPost hoc least squares difference test indicated a higher BNMN frequency in the exposed (plants A and B together) than
the controls in GSTM1 null subjects among both smokers (p = 0.006) and nonsmokers (p = 0.003), but in GSTM1 positive
subjects only among nonsmokers (p = 0.017).
Table 7. Mean (± SD) frequency of SCEs, percentage of high frequency cells, and PRI in shoe factory
workers and unexposed controls, according to smoking and GSTM1 genotype (last sampling).
Group, smoking habit Genotype No. No. SCEs/cell Percent HFC PRI
Controls
Nonsmokers GSTM1 null 6 7.70 ± 1.05 3.33 ± 3.50 2.28 ± 0.17
GSTM1 + 5 7.86 ± 1.08 2.40 ± 1.67 2.20 ± 0.38
Smokers GSTM1 null 7 8.89 ± 2.08 8.00 ± 11.83 2.27 ± 0.13
GSTM1 + 4 8.76 ± 1.48 7.69 ± 7.55 2.38 ± 0.06
Plant A workers
Nonsmokers GSTM1 null 7 7.49 ± 0.57 2.29 ± 2.14 2.14 ± 0.16
GSTM1 + 7 7.84 ± 1.07 3.14 ± 2.79 2.17 ± 0.16
Smokers GSTM1 null 11 8.31 ± 1.01 6.00 ± 3.69 2.23 ± 0.34
GSTM1 + 6 8.66 ± 1.38 6.33 ± 8.24 2.38 ± 0.13 
Plant B workers
Nonsmokers GSTM1 null 4 8.01 ± 0.86 6.00 ± 4.32 2.28 ± 0.14
GSTM1 + 3 7.53 ± 0.94 2.67 ± 2.31 2.32 ± 0.06
Smokers GSTM1 null 6 8.45 ± 1.44 5.08 ± 5.71 2.38 ± 0.09
GSTM1 + 3 7.05 ± 0.32 2.67 ± 3.06 2.31 ± 0.08
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